SEP 07, 2015 09:44 AM PDT

Regulatory T Cell Count Could Reduce Allergy Intensity

WRITTEN BY: Kara Marker
Our immune system is our protection against foreign invaders like harmful bacteria and viruses. When our immune cells recognize a particle as "foreign," they launch an attack that results in responses like inflammation, antibody production, and other actions to disarm the potentially harmful particle. Unfortunately, our immune system can err and recognize benign foreign particles as dangerous - like pollen, animal dander, lactose, and others, resulting in allergies. The immune system can also recognize the body's own cells as foreign - resulting in autoimmune disorders like rheumatoid arthritis, type 1 diabetes, and celiac disease (AAAAI). Fortunately, scientists at the Institute of Immunology at the Medical University of Vienna have been studying a way to reduce the development of allergies by increasing the activity of regulatory T cells. 

Regulatory T cells are responsible for making sure other lymphocytes don't attack the body's own cells.
Regulatory T cells are lymphocytes that respond to helper T cell activity, other immune cells that regulate adaptive immunity by activating other effector cells (Scandinavian Journal of Immunology). Regulatory T cells maintain the balance of immunological activity, ensuring recognition of the body's own cells while T helper cells patrol the body for foreign particles. Consequently, regulatory T cells play a primary role in preventing autoimmune disorders, suppressing allergic reactions, maintaining "maternal tolerance to the fetus," and protection of helpful bacteria of the microbiome. 

The study in Vienna, lead by Dr. Winfried F. Pickl, utilized a novel animal model to show a connection between increased regulatory T cell activity and reduced susceptibility to developing allergies. The model consisted of "double transgenic, humanized mice" so that, according to Pickl, they could "simulate in an animal model what happens in the human body when there is contact with a human-relevant allergen."

The group from Vienna is presenting their initial findings at the European Congress of Immunology in Vienna, which started yesterday and concludes tomorrow. Pickl and the other scientists involved in the study were able to stimulate increased regulatory T cell activity by using Interleukin-2, a T cell growth factor, and an "anti-Interleukin-2 antibody." Pickl explains that the antibody "decreases the half-life of IL-2 and generally prolongs its effect."


Although these results are only from preliminary experiments, there is much promise for future preventative treatments. These therapies could potentially be life-saving for patients at high risk of developing severe allergies or autoimmune disorders due to family history of disease or inability to produce proper amounts of regulatory T cells, as well as patients with an impaired T cell count due to viral diseases like HIV. 

Watch the video below to understand more the action of regulatory T cells as explained by Dr. Allison Bayer from the Department of Microbiology and Immunology and the Diabetes Research Institute at the University of Miami Miller School of Medicine. 



Source: Alpha Galileo 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 30, 2018
Immunology
JUL 30, 2018
Traumatic Childhood to Addiction, an Immune System Problem
Childhood adversity alters the immune system which contributes to increased risk of addiction as an adult....
AUG 17, 2018
Health & Medicine
AUG 17, 2018
Is Influenza Different in Obese Patients?
There are many health risks for obese patients. Cardiovascular disease, diabetes and even some forms of cancer. The immune system can be disrupted when a p...
SEP 05, 2018
Immunology
SEP 05, 2018
B Cells Contribute to Brain Lesions in Multiple Sclerosis
B cells lead to T cell activation resulting in damage to the myelin sheath and brain cells in multiple sclerosis pathogenesis....
SEP 26, 2018
Videos
SEP 26, 2018
Cancer Immunotherapy
Video illustration about how tumor cells are sensed and destroyed by the immune system and how tumors evolve and detect immune-mediated eliminations, as well as iimmunotherapies associated....
OCT 10, 2018
Microbiology
OCT 10, 2018
It's Time for Your Annual Flu Shot
After last year's flu season killed around 80,000 people, the CDC is trying to get the word out about the flu vaccine....
OCT 31, 2018
Immunology
OCT 31, 2018
Blood Clot Reduction
Vaccine developments to reduce blood clotting in stroke patients...
Loading Comments...